NCT04826770View on ClinicalTrials.gov

Adaptive Immune Response to COVID-19 Vaccination

Active, not recruitingOBSERVATIONAL

Enrollment

70

Participants

Timeline

Start Date

January 6, 2021

Primary Completion Date

December 13, 2021

Study Completion Date

December 31, 2023

Conditions

SARS-CoV-2 Vaccination

Interventions

DRUG

BNT162b2

vaccination against COVID-19

DRUG

AZD 1222

vaccination against COVID-19

DRUG

mRNA-1273

vaccination against COVID-19

Trial Locations (1)

17475

University Medicine Greifswald, Greifswald

All Listed Sponsors

lead

University Medicine Greifswald

OTHER